Three-drug combo improves lung function in most common genetic form of cystic fibrosis

A phase three clinical trial determined that a 3-drug combination improved lung function and reduced symptoms in cystic fibrosis (CF) patients who have a single copy of the most common genetic mutation for the disease. (source: sciencedaily.com)

(No Ratings Yet)

Loading...